SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2711"UPDATE 1-FDA staff raise safety issues with Arena diet drug" reutersRMP-9/14/2010
2710IDIX post-mortem, FWIW: siliconinvestor.comDewDiligence_on_SI-9/7/2010
2709Idenix (IDIX) off 48% after its all oral anti HCV combo runs into safety issues:tuck-9/7/2010
2708CellDex down over 30% in pre market on Pfizer's return of CDX-110 rights... pgo-neil-9/3/2010
2707Immunogen (IMGN) off 37% after partner Roche reports FDA refused to grant the atuck-8/27/2010
2706EpiCept's (EPCT) NDA for Ceplene in AML is rejected via refusal to file, stotuck-8/23/2010
2705Molecular Insight (MIPI) heads into penny stock territory, off 16% on no fresh ntuck-8/23/2010
2704jazz ah -25=30% UPDATE 3-US FDA panel rejects Jazz drug for fibromyalgia ThomsIan@SI-8/20/2010
2703PDLI in patent dispute with Roche/Genentech; shares off 18%: >>UPDATE 2-Ptuck-8/13/2010
2702ProPhase (nee Quigley) (PRPH) off 19% after reporting earnings. I know nada abotuck-8/12/2010
2701Cardiome (CRME), which had performed well since the referenced post, is off 16% tuck-8/11/2010
2700SCLN -33% on SEC/DoJ investigation: siliconinvestor.comDewDiligence_on_SI-8/10/2010
2699What will be interesting about the case is perhaps for the first time ever the Frkrw-8/5/2010
2698Well, the reload isn't looking that good right now. But the sale was a fourtuck-8/5/2010
2697Nice trades Tuck. Especially the $25 sale.Ian@SI-8/5/2010
2696Haven't looked into its burn rate, but this financing gave it a 3M+ share ovIan@SI-8/5/2010
2695MNTA: it's back at 15% right now. There are other catalysts, most notably ttuck-8/5/2010
2694Looks like MNTA hit the 15% bogey briefly this morning (9:48AM) on the Analyst TIan@SI-8/5/2010
2693Alexza (ALXA) off 16% on securities offering: Message 26735048 Methinks the datuck-8/5/2010
2692SRDX down about 15% on Q3 earnings i assume.idos-7/29/2010
2691Yes. The lawsuit may be a snowball in hell, but there was (is) a tolerable amountom pope-7/27/2010
2690I think it was actually the lawsuit. The stock did make an incredible run over jrkrw-7/27/2010
2689Dew, I'm not trying to say that the connection is rational, based on fact oIan@SI-7/27/2010
2688Assuming for the sake of discussion that your thesis about Brilinta is correct, DewDiligence_on_SI17/27/2010
2687You know that; and you frequently remind me of that; nevertheless, when the WSJ Ian@SI-7/27/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News